Group One Trading
STML

Group One Trading’s Stemline Therapeutics, Inc. STML Stock Holding History

Group One Trading’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-48,800
Closed -$236K – 6481
2020
Q1 		$236K Buy
48,800
+28,700
+143% +$186K ﹤0.01% 2627
2019
Q4 		$214K Buy
+20,100
New +$200K ﹤0.01% 3124
2019
Q3 		– Sell
-6,100
Closed -$93K – 5804
2019
Q2 		$93K Sell
6,100
-12,900
-68% -$187K ﹤0.01% 3414
2019
Q1 		$244K Buy
19,000
+15,000
+375% +$170K ﹤0.01% 2562
2018
Q4 		$38K Sell
4,000
-6,900
-63% -$89.5K ﹤0.01% 3697
2018
Q3 		$181K Hold
10,900
– – ﹤0.01% 3080
2018
Q2 		$175K Buy
+10,900
New +$195K ﹤0.01% 3157
2018
Q1 		– Sell
-2,800
Closed -$44K – 5559
2017
Q4 		$44K Buy
+2,800
New +$37.4K ﹤0.01% 3802
2017
Q2 		– Sell
-5,800
Closed -$50K – 5303
2017
Q1 		$50K Buy
+5,800
New +$52.9K ﹤0.01% 3408
2015
Q4 		– Sell
-2,000
Closed -$18K – 5300
2015
Q3 		$18K Buy
+2,000
New +$21K ﹤0.01% 4091

Group One Trading's STML Position: Q2 2020 in Review

Group One Trading sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 26,780 shares — an estimated $130K sold.

Group One Trading first reported a position in STML in Q3 2015 and held it in 12 quarters. The position peaked at $130K in Q1 2020. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • Group One Trading reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Group One Trading sold 26,780 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $130K.
  • Group One Trading first reported a position in Stemline Therapeutics, Inc. in Q3 2015 and held it in 12 quarters.
  • Group One Trading's Stemline Therapeutics, Inc. position peaked at $130K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Group One Trading's 13F filing for Q2 2020, filed 13 Aug 2020.